These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 38155967)

  • 1. Comprehensive analysis of the prognostic implication and immune infiltration of CISD2 in diffuse large B-cell lymphoma.
    Zhang C; Lin Q; Li C; Qiu Y; Chen J; Zhu X
    Front Immunol; 2023; 14():1277695. PubMed ID: 38155967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying
    Xiang X; Gao LM; Zhang Y; Zhu Q; Zhao S; Liu W; Ye Y; Tang Y; Zhang W
    PeerJ; 2023; 11():e16618. PubMed ID: 38099311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction significance of autophagy-related genes in survival probability and drug resistance in diffuse large B-cell lymphoma.
    Xiong D; Wei X; Huang W; Zheng J; Feng R
    Aging (Albany NY); 2024 Jan; 16(2):1049-1076. PubMed ID: 38240686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and Validation of a Prognostic Prediction Model in Diffuse Large B-Cell Lymphoma.
    Yan J; Yuan W; Zhang J; Li L; Zhang L; Zhang X; Zhang M
    Front Endocrinol (Lausanne); 2022; 13():846357. PubMed ID: 35498426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCL8 as a promising prognostic factor in diffuse large B-cell lymphoma
    Lou X; Zhao K; Xu J; Shuai L; Niu H; Cao Z; Wang J; Zhang Y
    Front Immunol; 2022; 13():950213. PubMed ID: 36072582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune scoring model based on immune cell infiltration to predict prognosis in diffuse large B-cell lymphoma.
    Yang J; Yu L; Man J; Chen H; Zhou L; Zhao L
    Cancer; 2023 Jan; 129(2):235-244. PubMed ID: 36345617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of lactate regulation pattern on tumor immune infiltration, therapy response, and DNA methylation in diffuse large B-cell lymphoma.
    Wang J; Wang Y; Wan L; Chen X; Zhang H; Yang S; Zhong L
    Front Immunol; 2023; 14():1230017. PubMed ID: 37790933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and Validation of a DNA Damage Repair-Related Signature for Diffuse Large B-Cell Lymphoma.
    Li Y; Liu X; Chang Y; Fan B; Shangguan C; Chen H; Zhang L
    Biomed Res Int; 2022; 2022():2645090. PubMed ID: 36281462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of endoplasmic reticulum stress-related gene signature for the prognosis and pattern in diffuse large B cell lymphoma.
    Zhang C; Lin Q; Li C; Chen Z; Deng M; Weng H; Zhu X
    Sci Rep; 2023 Aug; 13(1):13894. PubMed ID: 37626099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrative analysis of a necroptosis-related gene signature of clinical value and heterogeneity in diffuse large B cell lymphoma.
    Pan YB; Wang W; Cai HK; Zhang J; Teng Y; Xue J; Zhu M; Luo WD
    Front Genet; 2022; 13():911443. PubMed ID: 36035126
    [No Abstract]   [Full Text] [Related]  

  • 11. Identification of molecular subtypes and a novel prognostic model of diffuse large B-cell lymphoma based on a metabolism-associated gene signature.
    He J; Chen Z; Xue Q; Sun P; Wang Y; Zhu C; Shi W
    J Transl Med; 2022 Apr; 20(1):186. PubMed ID: 35468826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Machine-learning-based classification of diffuse large B-cell lymphoma patients by a 7-mRNA signature enriched with immune infiltration and cell cycle.
    Zhuang X; Liu B; Long J; Wang H; Yu J; Ji X; Li J; Zhu N; Li L; Chen Y; Liu Z; Zhao S
    Clin Transl Oncol; 2024 Apr; 26(4):936-950. PubMed ID: 37783922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and Development of a 4-Gene Ferroptosis Signature Predicting Overall Survival for Diffuse Large B-Cell Lymphoma.
    Wu H; Zhang J; Fu L; Wu R; Gu Z; Yin C; He K
    Technol Cancer Res Treat; 2023; 22():15330338221147772. PubMed ID: 36762399
    [No Abstract]   [Full Text] [Related]  

  • 14. Bioinformatic prediction of miR-320a as a potential negative regulator of CDGSH iron-sulfur domain 2 (
    Zhao X; Li L; Li Y; Liu Y; Wang H; Tabrizi NS; Ye Z; Zhao Z
    Transl Cancer Res; 2024 Aug; 13(8):4485-4499. PubMed ID: 39262456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a novel model based on ferroptosis-related genes for predicting the prognosis of diffuse large B-cell lymphomas.
    Wang J; Peng H; Zhang G; Yan W
    Hematology; 2023 Dec; 28(1):2198862. PubMed ID: 37199349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of USP18 reduces tumor-infiltrating activated dendritic cells in extranodal diffuse large B cell lymphoma patients.
    Zhao C; Huang R; Zeng Z; Yang S; Lu W; Liu J; Wei Y; Guo H; Zhang Y; Yan P; Huang Z; Shi J
    Aging (Albany NY); 2021 May; 13(10):14131-14158. PubMed ID: 34001679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel NET-related gene signature for predicting DLBCL prognosis.
    Shi H; Pan Y; Xiang G; Wang M; Huang Y; He L; Wang J; Fang Q; Li L; Liu Z
    J Transl Med; 2023 Sep; 21(1):630. PubMed ID: 37716978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Immune-Related Prognostic Classifier Is Associated with Diffuse Large B Cell Lymphoma Microenvironment.
    Liang XJ; Fu RY; Wang HN; Yang J; Yao N; Liu XD; Wang L
    J Immunol Res; 2021; 2021():5564568. PubMed ID: 34212052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An integrative bioinformatics investigation and experimental validation of chromobox family in diffuse large B-cell lymphoma.
    Zhou F; Chen L; Lu P; Cao Y; Deng C; Liu G
    BMC Cancer; 2023 Jul; 23(1):641. PubMed ID: 37430195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural killer cell-associated prognosis model characterizes immune landscape and treatment efficacy of diffuse large B cell lymphoma.
    Xiao W; Yu K; Deng X; Zeng Y
    Cytokine; 2024 Oct; 182():156726. PubMed ID: 39111113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.